Back
Galderma Group AG Vs. NLS Pharmaceutics Industry Stock Comparison
Buy
83
GDERF
Galderma Group AG
Last Price:
97.00
Seasonality Move:
--
Sell
31
NLSP
NLS Pharmaceutics
Last Price:
2.03
Seasonality Move:
9.94%
Buy
83
Galderma Group AG (GDERF)
is a Buy
Is Galderma Group AG a Buy, Sell or Hold?
- The current Galderma Group AG [GDERF] share price is $97.00. The Score for GDERF is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
- GDERF is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
31
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $2.01. The Score for NLSP is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GDERF Stock Price Chart
What is Galderma Group AG's stock price today?
-
The Galderma Group AG share price today is $97.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GDERF is experiencing slight buying pressure.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $2.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
GDERF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.3 | Buy |
| Relative Strength Index (14 RSI): | 99.8 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (91.39 - 98.57) | Buy |
| Bollinger Bands (100): | (79.95 - 91.61) | Buy |
NLSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.54 | Sell |
| Relative Strength Index (14 RSI): | 24.87 | Sell |
| Chaikin Money Flow: | 1743438 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.52 - 3.82) | Sell |
| Bollinger Bands (100): | (3.48 - 7.04) | Sell |
GDERF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 97 | Sell |
| 20-day SMA: | 96.58 | Buy |
| 50-day SMA: | 88.89 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 96.92 | Buy |
| 20-day EMA: | 95.35 | Buy |
| 50-day EMA: | 90.93 | Buy |
| 200-day EMA: | 9.23 | Buy |
NLSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.36 | Sell |
| 20-day SMA: | 2.96 | Sell |
| 50-day SMA: | 3.87 | Sell |
| 200-day SMA: | 6.39 | Sell |
| 8-day EMA: | 2.35 | Sell |
| 20-day EMA: | 2.89 | Sell |
| 50-day EMA: | 3.78 | Sell |
| 200-day EMA: | 8.51 | Sell |
Galderma Group AG Earnings Growth & GDERF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Galderma Group AG Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NLS Pharmaceutics Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||